drugset / Trial / NCT04162743

The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression

NCT04162743

Phase 4 Completed 22 enrolled Chang Gung Memorial Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

The investigators hypothesize that trazodone does not worse nocturnal oxygen saturation in insomnic ischemic stroke patients with obstructive sleep apnea (OSA) and depression and has beneficial effect in selected stroke patients with low arousal threshold phenotype OSA.

Timeline

Start
2019-02-01
Primary completion
2020-03-31
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Trazodone Small molecule 100 mg